Pamela Wedel, BSc

Vice President, Clinical Operations
Amplyx Pharmaceuticals

Disclosure: Amplyx Pharmaceuticals (Individual(s) Involved: Self): Employee

Presentation(s):

• 147 - Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

  Oral Abstract